Atom Investors LP lowered its position in ACM Research, Inc. (NASDAQ:ACMR - Free Report) by 48.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 55,006 shares of the specialty retailer's stock after selling 50,722 shares during the period. Atom Investors LP owned 0.10% of ACM Research worth $1,117,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Erste Asset Management GmbH purchased a new stake in shares of ACM Research during the 3rd quarter valued at approximately $37,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of ACM Research by 255.5% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 36,123 shares of the specialty retailer's stock valued at $733,000 after acquiring an additional 25,963 shares during the period. Cynosure Group LLC boosted its holdings in shares of ACM Research by 30.7% in the 3rd quarter. Cynosure Group LLC now owns 20,996 shares of the specialty retailer's stock valued at $426,000 after buying an additional 4,930 shares in the last quarter. FMR LLC raised its position in ACM Research by 507.4% during the 3rd quarter. FMR LLC now owns 15,185 shares of the specialty retailer's stock worth $308,000 after buying an additional 12,685 shares during the last quarter. Finally, Truvestments Capital LLC acquired a new stake in ACM Research in the 3rd quarter valued at $72,000. Institutional investors and hedge funds own 66.75% of the company's stock.
Insiders Place Their Bets
In related news, insider David H. Wang sold 56,250 shares of the company's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $17.89, for a total value of $1,006,312.50. Following the completion of the transaction, the insider now directly owns 654,256 shares in the company, valued at approximately $11,704,639.84. The trade was a 7.92 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Science & Technology Shanghai sold 275,000 shares of ACM Research stock in a transaction on Monday, October 7th. The shares were sold at an average price of $24.07, for a total value of $6,619,250.00. Following the transaction, the insider now owns 2,428,906 shares of the company's stock, valued at $58,463,767.42. The trade was a 10.17 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,244,016 shares of company stock valued at $26,939,953. Company insiders own 31.24% of the company's stock.
ACM Research Stock Performance
Shares of ACMR stock traded up $0.37 during trading hours on Wednesday, hitting $16.57. The company's stock had a trading volume of 2,093,622 shares, compared to its average volume of 1,449,356. The company has a current ratio of 2.37, a quick ratio of 1.34 and a debt-to-equity ratio of 0.10. The stock has a market cap of $954.60 million, a PE ratio of 12.55 and a beta of 1.48. ACM Research, Inc. has a 12-month low of $13.94 and a 12-month high of $34.40. The company has a 50 day moving average of $19.16 and a 200 day moving average of $19.96.
ACM Research (NASDAQ:ACMR - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The specialty retailer reported $0.63 EPS for the quarter, topping the consensus estimate of $0.28 by $0.35. The business had revenue of $204.00 million for the quarter, compared to analyst estimates of $191.18 million. ACM Research had a net margin of 12.38% and a return on equity of 9.07%. The business's revenue for the quarter was up 21.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.41 EPS. On average, sell-side analysts forecast that ACM Research, Inc. will post 1.12 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts have issued reports on the company. Needham & Company LLC cut ACM Research from a "buy" rating to a "hold" rating and set a $25.00 price objective for the company. in a research report on Wednesday. Benchmark reissued a "buy" rating and set a $38.00 price objective on shares of ACM Research in a report on Wednesday, August 7th. Finally, Roth Mkm decreased their price objective on ACM Research from $40.00 to $30.00 and set a "buy" rating for the company in a research note on Thursday, August 8th.
Read Our Latest Analysis on ACMR
ACM Research Profile
(
Free Report)
ACM Research, Inc, together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating.
Featured Stories
Before you consider ACM Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ACM Research wasn't on the list.
While ACM Research currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.